Acumen Pharmaceuticals (ABOS) Earnings Date, Estimates & Call Transcripts $1.40 -0.05 (-3.13%) As of 12:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acumen Pharmaceuticals Earnings Summary Acumen Pharmaceuticals announced Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.68, which missed the consensus estimate of -$0.54 by $0.14. With a trailing EPS of -$2.28, Acumen Pharmaceuticals' earnings are expected to decrease next year, from ($1.56) to ($1.79) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.54 Actual EPS (Aug. 12) -$0.68 Missed By -$0.14 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)ABOS Upcoming EarningsAcumen Pharmaceuticals' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Acumen Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acumen Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataABOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Acumen Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.56) EPSNext Year EPS Consensus Estimate ($1.79) EPS Acumen Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/12/2025Q2 2025-$0.54-$0.68 -$0.14-$0.68--5/13/2025Q1 2025-$0.56-$0.48+$0.08-$0.48--3/27/2025Q4 2024-$0.47-$0.62 -$0.15-$0.62--11/12/2024Q3 2024-$0.36-$0.50 -$0.14-$0.50--8/13/2024Q2 2024-$0.28-$0.34 -$0.06-$0.34--5/20/2024Q1 2024-$0.23-$0.25 -$0.02-$0.25--3/26/2024Q4 2023-$0.29-$0.29--$0.29--11/13/2023Q3 2023-$0.31-$0.24+$0.07-$0.24-- Acumen Pharmaceuticals Earnings - Frequently Asked Questions When is Acumen Pharmaceuticals' earnings date? Acumen Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on ABOS's earnings history. Did Acumen Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Acumen Pharmaceuticals (NASDAQ:ABOS) missed the analysts' consensus estimate of ($0.54) by $0.14 with a reported earnings per share (EPS) of ($0.68). Learn more on analysts' earnings estimate vs. ABOS's actual earnings. How can I listen to Acumen Pharmaceuticals' earnings conference call? The conference call for Acumen Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Acumen Pharmaceuticals' conference call transcript? The conference call transcript for Acumen Pharmaceuticals' latest earnings report can be read online. Read Transcript How much profit does Acumen Pharmaceuticals generate each year? Acumen Pharmaceuticals (NASDAQ:ABOS) has a recorded net income of -$102.33 million. ABOS has generated -$2.28 earnings per share over the last four quarters. What is Acumen Pharmaceuticals' EPS forecast for next year? Acumen Pharmaceuticals' earnings are expected to decrease from ($1.56) per share to ($1.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies 4D Molecular Therapeutics Earnings Results Altimmune Earnings Results Aldeyra Therapeutics Earnings Results Foghorn Therapeutics Earnings Results Larimar Therapeutics Earnings Results Contineum Therapeutics Earnings Results DiaMedica Therapeutics Earnings Results Amarin Earnings Results Tectonic Therapeutic Earnings Results Korro Bio Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why DocuSign Could Be a SaaS Value Play After Q2 EarningsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a WinnerWhat to Watch for From D-Wave Now That Earnings Are DoneDICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples Play This page (NASDAQ:ABOS) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acumen Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
